Daytrana Vs. Adderall Xr
- Daytrana TD Precautions and Side Effects
- Dosage and Storage
- Precautions and Side Effects
- Drug Interactions
Pronounced: (meth-ill-FEN-eh-date)
Warning
Misuse or abuse of methylphenidate may result in serious (possibly fatal) heart and blood pressure problems.
Methylphenidate should be given cautiously to emotionally unstable patients, especially if there is a history of alcohol or drug abuse. These patients may be more likely to unnecessarily increase their doses or use this medication too often. Long-term overuse of this medication may lead to drug...
Read moreMore information on "Daytrana Vs. Adderall Xr"
From Our Sources
Daytrana
Brand Name: Daytrana Generic Name: methylphenidate Usage The U.S. Food and Drug Administration (FDA) have approved Daytrana for the treatment... Read more »
Concerta, Daytrana, Metadate CD, Methylin, Ritalin, Ritalin SR...
Brand Name: Concerta, Daytrana, Metadate CD, Methylin, Ritalin, Ritalin SR, Ritalin LA Generic Name: methylphenidate Usage Concerta ... Read more »
Adderall and Adderall XR
Brand Name: Adderall and Adderall XR Generic Name: amphetamine, dextroamphetamine Usage: Adderall and Adderall XR have been approved by the... Read more »
Desoxyn
Brand Name: Desoxyn Generic Name: methamphetamine Usage The U.S. Food and Drug Administration have approved Desoxyn for the treatment of... Read more »
Focalin and Focalin XR
Brand Name: Focalin and Focalin XR Generic Name: dexmethylphenidate hydrochloride Usage Focalin is a short acting stimulant medication and is... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
